Sandoz Private Limited — Citalopram Exporter Profile
Indian Pharmaceutical Exporter · #7 for Citalopram · $12.9M export value · DGFT Verified
Sandoz Private Limited is the #7 Indian exporter of Citalopram with $12.9M in export value and 281 verified shipments. Sandoz Private Limited holds a 5.1% market share in Citalopram exports across 9 countries. The company exports 25 pharmaceutical products worth $159.4M across 15 therapeutic categories.
Sandoz Private Limited — Citalopram Export Profile: Buyers & Destinations
Where Does Sandoz Private Limited Export Citalopram?
| Country | Value | Shipments | Share |
|---|---|---|---|
| POLAND | $4.4M | 143 | 49.4% |
| BRAZIL | $1.5M | 36 | 17.0% |
| KOREA,REPUBLIC OF | $636.7K | 17 | 7.1% |
| SLOVENIA | $478.8K | 17 | 5.4% |
| REPUBLIC OF KOREA | $459.3K | 10 | 5.1% |
| CANADA | $345.7K | 13 | 3.9% |
| THAILAND | $272.5K | 14 | 3.0% |
| COLOMBIA | $267.0K | 7 | 3.0% |
| SOUTH KOREA | $248.5K | 6 | 2.8% |
| KOREAREPUBLIC OF | $150.0K | 3 | 1.7% |
Sandoz Private Limited exports Citalopram to 12 countries. The largest destination is POLAND accounting for 49.4% of Sandoz Private Limited's Citalopram shipments, followed by BRAZIL (17.0%) and KOREA,REPUBLIC OF (7.1%). These destinations reflect Sandoz Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Citalopram from Sandoz Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LEK S.A. | POLAND | $3.0M | 112 |
| LEK S A | POLAND | $1.5M | 31 |
| SANDOZ DO BRASIL IND FARMACEUTICA | BRAZIL | $802.4K | 20 |
| SANDOZ DO BRASIL IND FARMAC?UTICA | BRAZIL | $593.9K | 13 |
| SAMIL PHARMACEUTICAL CO., LTD. | REPUBLIC OF KOREA | $365.5K | 8 |
| HEXAL (SANDOZ) KOREA | KOREA,REPUBLIC OF | $359.6K | 11 |
| NOVARTIS LLC - PM - PRODUCTION MATE | SLOVENIA | $303.5K | 10 |
| SANDOZ KOREA LTD. | KOREA,REPUBLIC OF | $277.1K | 6 |
| SANDOZ CANADA INC. | CANADA | $257.6K | 7 |
| SANDOZ KOREA LIMITED | SOUTH KOREA | $248.5K | 6 |
Sandoz Private Limited supplies Citalopram to 32 buyers globally. The largest buyer is LEK S.A. (POLAND), followed by LEK S A (POLAND) and SANDOZ DO BRASIL IND FARMACEUTICA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Citalopram Export Value and How Much Does Sandoz Private Limited Contribute?
India exported $148.8M worth of Citalopram through 7,372 shipments from 257 suppliers to 101 countries, serving 736 buyers globally. Sandoz Private Limited contributes $12.9M to this total, accounting for 5.1% of India's Citalopram exports. Sandoz Private Limited ships Citalopram to 12 countries through 32 buyers.
What Is the Average Shipment Value for Sandoz Private Limited's Citalopram Exports?
Sandoz Private Limited's average Citalopram shipment value is $46.1K per consignment, based on 281 shipments totaling $12.9M. The largest destination is POLAND (49.4% of Sandoz Private Limited's Citalopram exports).
How Does Sandoz Private Limited Compare to Other Indian Citalopram Exporters?
Sandoz Private Limited ranks #7 among 257 Indian Citalopram exporters with a 5.1% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($28.0M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($23.0M), TORRENT PHARMACEUTICALS LTD ($17.3M). Sandoz Private Limited processed 281 shipments to 9 destination countries.
What Citalopram Formulations Does Sandoz Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Material No. - 42034110 ESCITALOPRAM OXA | $400.0K | 8 |
| ESCITALOPRAM OXA FCT 10MG IN91 SH EU 04 | $350.0K | 7 |
| MATERIAL NO. 42034100 ESCITALOPRAMOXA FCT 20MG IN91 SH EU 05 | $347.1K | 18 |
| MATERIAL NO. 42034110 ESCITALOPRAMOXA FCT 10MG IN91 SH EU 04 | $223.5K | 9 |
| Material No. - 42030715, ESCITALOPRAM OX | $200.0K | 4 |
| ESCITALOPRAM OXA FCT 10MG IN91 SH EU 06MATERIAL NO 42039084 | $200.0K | 4 |
| Material No. - 42034100 ESCITALOPRAM OXA | $150.0K | 3 |
| ESCITALOPRAM OXA FCT 20MG IN91 SH EU 05 | $150.0K | 3 |
| ESCITALOPRAM OXA FCT 20MG IN91 SH EU 07MATERIAL NO 42039083 | $150.0K | 3 |
| MATERIAL NO-42030715 ESCITALOPRAM OXA FCT 20MG IN91 SH MSPCS | $149.2K | 3 |
Sandoz Private Limited exports 151 distinct Citalopram formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Material No. - 42034110 ESCITALOPRAM OXA with 8 shipments worth $400.0K.
Regulatory Requirements: Exporting Citalopram to Key Markets
What Sandoz Private Limited must comply with to export Citalopram to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Sandoz Private Limited Compare to Nearest Citalopram Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | TORRENT PHARMACEUTICALS LTD | $17.3M | 345 | 15 | $50.0K |
| 6 | AUROBINDO PHARMA LIMITED | $13.5M | 420 | 14 | $32.0K |
| 7 | SANDOZ PRIVATE LIMITED ★ | $12.9M | 281 | 9 | $46.1K |
| 5 | MYLAN LABORATORIES LIMITED | $10.1M | 202 | 4 | $50.0K |
| 8 | CIPLA LIMITED | $8.2M | 239 | 7 | $34.5K |
Sandoz Private Limited ranks #7 among 257 Indian Citalopram exporters. Average shipment value of $46.1K compared to the market average of $579.1K. The closest competitors by value are TORRENT PHARMACEUTICALS LTD and AUROBINDO PHARMA LIMITED.
Which Indian Ports Ship Citalopram Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 779 | 10.6% |
| SAHAR AIR | 684 | 9.3% |
| NHAVA SHEVA SEA (INNSA1) | 609 | 8.3% |
| HYDERABAD ICD | 593 | 8.0% |
| HYDERABAD ICD (INSNF6) | 411 | 5.6% |
| HYDERABAD AIR | 336 | 4.6% |
| DELHI AIR CARGO ACC (INDEL4) | 334 | 4.5% |
| DELHI AIR | 309 | 4.2% |
What Other CNS & Psychiatric Products Does Sandoz Private Limited Export?
Sandoz Private Limited also exports these cns & psychiatric products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Sandoz Private Limited's Citalopram Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Sandoz Private Limited. The escalation of conflicts in West Asia, particularly between Israel and Iran, has disrupted vital trade corridors such as the Red Sea and the Strait of Hormuz. These disruptions have led to increased shipping costs and extended transit times, impacting the timely delivery of pharmaceutical products. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned that prolonged disruptions could result in potential losses of up to ₹5,000 crore for the industry. (timesofindia.indiatimes.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Sandoz's established presence and compliance with international quality standards position it favorably to capitalize on this shift. However, the company must navigate the complexities of the European Union's Falsified Medicines Directive, which imposes stringent regulations to prevent counterfeit medicines from entering the supply chain. Adherence to these regulations is crucial for maintaining access to the lucrative EU market.
Sandoz Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Sandoz Private Limited. The company adheres to guidelines set forth by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). Maintaining these certifications ensures the quality and safety of its products, facilitating access to global markets.
The evolving regulatory environment necessitates continuous investment in quality assurance and compliance. Sandoz's commitment to these standards not only mitigates the risk of regulatory actions but also enhances its reputation as a reliable supplier in the competitive pharmaceutical export market.
About Sandoz Private Limited
Sandoz Private Limited exports 25 products worth $159.4M. Beyond Citalopram, top products include Tacrolimus, Apixaban, Escitalopram, Gabapentin, Mycophenolate. View the complete Sandoz Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Citalopram — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Citalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sandoz Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 281 individual customs records matching Sandoz Private Limited exporting Citalopram, covering 151 formulations to 12 countries via 32 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 101+ countries, 736+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Citalopram Export Data from Sandoz Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sandoz Private Limited's Citalopram exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sandoz Private Limited
Full Company Profile →
25 products · $159.4M total trade · 15 categories
Citalopram Stats
Company Overview
Top Products by Sandoz Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sandoz Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Citalopram. For current shipment-level data, contact TransData Nexus.